Key result
Adding neuroimaging to clinical-lab models improves post-stroke AF prediction to an AUC of ~0.84.
Why the study?
Atrial fibrillation detected after stroke increases the risk of stroke recurrence and death, but validated predictive tools to assess this risk were lacking.
Does a nomogram incorporating clinical, laboratory, and neuroimaging variables accurately predict the incidence of atrial fibrillation detected after acute ischemic stroke?
Cohort (n=5,332)
Yes
Does a nomogram incorporating clinical, laboratory, and neuroimaging variables accurately predict the incidence of atrial fibrillation detected after acute ischemic stroke?
Absolute Event Rate: 0.841% vs 0.808%
p-value: p=0.001
May refine post-stroke AF stratification; extends prior models but remains hypothesis-generating pending validation.
Background Atrial fibrillation detected after stroke (AFDAS) is associated with an increased risk of ischemic stroke (IS) recurrence and death. Early diagnosis can help identify strategies for secondary prevention and improve prognosis. However, there are no validated predictive tools to assess the population at risk for AFDAS. Therefore, this study aimed to develop and validate a predictive model for assessing the incidence of AFDAS after acute ischemic stroke (AIS). Methods This study was a multicenter retrospective study. We collected clinical data from 5332 patients with AIS at two hospitals between 2014.01 and 2021.12 and divided the development and validation of clinical prediction models into a training cohort ( n = 3173) and a validation cohort ( n = 2159). Characteristic variables were selected from the training cohort using the least absolute shrinkage and selection operator (LASSO) algorithm and multivariable logistic regression analysis. A nomogram model was developed, and its performance was evaluated regarding calibration, discrimination, and clinical utility. Results We found the best subset of risk factors based on clinical characteristics and laboratory variables, including age, congestive heart failure (CHF), previous AIS/transient ischemia attack (TIA), national institutes of health stroke scale (NIHSS) score, C-reactive protein (CRP), and B-type natriuretic peptide (BNP). A predictive model was developed. The model showed good calibration and discrimination, with calibration values of Hosmer-Lemeshow χ 2 = 4.813, P = 0.732 and Hosmer-Lemeshow χ 2 = 4.248, P = 0.834 in the training and validation cohorts, respectively. The area under the ROC curve (AUC) was 0.815, 95% CI (0.777–0.853) and 0.808, 95% CI (0.770–0.847). The inclusion of neuroimaging variables significantly improved the performance of the integrated model in both the training cohort (AUC. 0.846 (0.811–0.882) vs. 0.815 (0.777–0.853), P = 0.001) and the validation cohort (AUC: 0.841 (0.804–0.877) vs. 0.808 (0.770–0.847), P = 0.001). The decision curves showed that the integrated model added more net benefit in predicting the incidence of AFDAS. Conclusion Predictive models based on clinical characteristics, laboratory variables, and neuroimaging variables showed good calibration and high net clinical benefit, informing clinical decision-making in diagnosing and treating patients with AFDAS.
No takes yet. Share an insight, caveat, or question.
Pang et al. (2022) conducted a cohort in Acute ischemic stroke (n=5,332). Integrated prediction model (Model 2: clinical, laboratory, and neuroimaging variables) vs. Clinical and laboratory prediction model (Model 1) was evaluated on Area under the ROC curve (AUC) for predicting atrial fibrillation detected after stroke in the validation cohort (95% CI 0.804-0.877, p=0.001). An integrated nomogram model combining clinical, laboratory, and neuroimaging variables significantly improved the prediction of atrial fibrillation detected after acute ischemic stroke compared to a clinical-laboratory model (AUC 0.841 vs 0.808).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: